Does aspirin enhance the clinical response to pre-operative chemo-radiotherapy in rectal cancer?
Advances in surgical resection, development of adjuvant therapies and efforts to optimise early detection, have led to a reduction in colorectal cancer mortality rates, but despite this progress around 40% of patients still die from recurrence or metastatic disease. Poor response to adjuvant treatme...
Main Author: | Gash, Katherine Jane |
---|---|
Published: |
University of Bristol
2016
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.702133 |
Similar Items
-
Risk stratification in rectal cancer : identifying tumours resistant to pre-operative radiotherapy
by: Parker, Alexandra
Published: (2012) -
Epithelial mesenchymal transition and resistance to neoadjuvant radiotherapy in locally advanced rectal cancer
by: Bhangu, Aneel
Published: (2014) -
The role of aspirin and statins in colorectal cancer survival
by: Gray, Ronan T.
Published: (2017) -
The pathophysiological effects of adjuvant preoperative chemotherapy and/or radiotherapy on patients with advanced rectal cancer : 'neoadjuvant treatment is a two edged sword in patients with advanced colorectal cancer'
by: Rahmani, Samir
Published: (2013) -
Exploration of the clinical interaction between vascular targeting agents and radiotherapy
by: Mandeville, H. C.
Published: (2011)